To address the significant problem of opioid use in pregnancy and associated high numbers of babies born with neonatal abstinence syndrome or neonatal opioid withdrawal syndrome, the Centers for Medicare & Medicaid Services (CMS) awarded cooperative agreements to 10 state Medicaid agencies to implement the Maternal Opioid Misuse (MOM) Model. By supporting the coordination of clinical care and the integration of other critical services, the MOM Model has the potential to improve quality of care and reduce costs for mothers and infants.
Insight is developing qualitative, process, and impact evaluation designs to conduct 10 individual model awardee evaluations and a cross-site evaluation. The MOM evaluation is based on a mixed-methods framework and will include numerous rounds of key informant interviews, beneficiary focus groups, beneficiary interviews, and qualitative data analysis using NVivo. Analysis of participant-level process data will provide characteristics of MOM enrollees, their experiences and service use, and ongoing examination of the outcomes associated with program participation. The implementation period will include impact analyses, leveraging T-MSIS (Medicaid) data, vital statistics, and use of other awardee-specific or publicly available data to measure the model’s effects on quality, health outcomes, and costs.
For this 5-year evaluation, Insight is using innovative approaches such as—
- A mixed-methods integration team
- Photovoice for capturing beneficiary-level data
- Natural language processing to identify themes in early qualitative data
The mixed-methods evaluation will determine the impact of MOM on healthcare delivery, health outcomes, patient experiences, utilization, and cost for pregnant and postpartum Medicaid beneficiaries with opioid use disorder and their infants.
Evaluation design reports; environmental scans and literature reviews; case study reports; annual reports; infobriefs; conference presentations; special studies